The conformation of the valinomycin-lithium complex has been studied using CD and nmr techniques. The lithium ion induced significant changes in the chemical shifts of the NH and CaH protons. as well as in the CD spectra of valinomycin. From the analysis of the lithium ion titration data, it is concluded that valinomycin forms a 1:l type weak complex with lithium, having a stability constant of 48 L mol-l at 25OC. This conformation is different from the familiar valinomycin-potassium complex. T h e nature of the interaction at low and high concentrations of lithium ions with valinomycin (ionophore) and gramicidin-S (nonionophore) has been compared. At high salt concentrations, there was a further change in the C D and nmr spectra of valinomycin, giving a second plateau region a t >3M of the salt. In the case of gramicidin-S, no significant changes in the nmr or CD spectra were observed in the lower concentration range corresponding to where changes were observed in the case of valinomycin. However, the addition of lithium salt at concentrations greater than 3M induced changes in both the CD and nmr spectra of gramicidin-S, and the titration graph of molar ellipticity versus concentration of lithium perchlorate gave a plateau region at concentrations greater than this. These results indicate that the effects of lithium a t low and high concentrations are independent of each other. The conformational transitions at very high salt concentrations (denaturation) are more likely due to solvent structural perturbations rather than to the consequences of ion binding.
INTRODUCTION
The effects of alkali metal cations on the conformations of biological macromolecules are of importance in understanding their functions. At low concentrations of salts, appropriate stoichiometric meta1:peptide complexes may be formed. For example, the cation binding properties of ionophoric peptides, depsipeptides, and polyethers are well documented.' A t high concentrations of the salts, it is well known that proteins and polypeptides are denatured.2 However, the question of whether, and how, the site binding is related to denaturation does not seem to be very well understood. An answer to this question is of interest, since both involve conformational changes. One way of approaching such a problem would be to compare the effects of the addition of salts at varying concentrations on ionophoric and nonionophoric systems. We have chosen valinomycin' and gramicidin-S3 for this purpose.
The ability of valinomycin to selectively transport potassium ions has led to a detailed characterization of its complexes with the monovalent alkali metal cations, Na+, K+, Rb+, and Cs+.' The complexation of the lithium ion has always been considered weak, and no systematic investigations have been carried out to characterize it otherwise. Because Fthium transport4 across biological membranes is not as clearly understood as potassium and sodium transport, it is important to characterize the complex. Although valinomycin is known to be a potential ionophore for potassium acting through a carrier mechanism, the various steps of the transport (the complexation and decomplexation at the interface, diffusion across the membrane, etc.) have not been experimentally demonstrated.
In our laboratory, we are studying valinomycin and its complexes with a variety of cations of varying size and charge to try to understand all the possible conformations the complex can take. Recent investigations of the valinomycin-barium system5v6 have demonstrated the existence of 1:2. 1:1, and 2:l va1inomycin:barium complexes. In this paper, we report our investigations on the valinomycin-lithium complex and the effects of high concentrations of lithium salt on the conformations of valinomycin and gramicidin-S, in the lipophilic solvent acetonitrile.
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EXPERIMENTAL
Valinomycin and gramicidin-S were from Sigma Chemical Company. Lithium perchlorate was purchased from Alfa Chemical Company, and acetonitrile-da was from Stohler Isotope Chemicals. Acetonitrile used for CD measurements was distilled after refluxing over P205 for 2-3 h. Solutions for the titrations were prepared by appropriate mixing of the stock solutions of valinomycin and valinomycin plus lithium perchlorate in acetonitrile. The valinomycin concentration used for both CD and proton nmr experiments was -5 mM. CD spectra were recorded on the Jasco 5-20 spectropolarimeter. 'H-and 13C-nmr experiments were done on a Bruker WH-270 Fourier-transform nmr instrument equipped with a variabletemperature accessory. Spectra were obtained in the Fourier-transform mode and were generally the result of 25-50 accumulations for 'H-nmr and 150-200 for 13C-nmr. Chemical shifts are expressed ppm downfield from TMS as the internal reference. AU experiments were done at a temperature of 25OC.
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CD Studies
The CD spectra of valinomycin in acetonitrile ( Fig. 1) range is given in Fig. 3 .
In the case of gramicidin-S, no CD spectral changes were observed even at the [lithium]/[valinomycin] ratio of 100 (Fig. 2) . The spectral changes were observed only at high salt concentration. The CD spectra of gramicidin-S in acetonitrile, containing a minimum amount of methanol, with no salt, and with 3.5M lithium perchlorate are shown in Fig. 4 . The solu- bility of gramicidin-S in acetonitrile is limited; hence, a minimum amount of methanol is used to solubilize gramicidin-S in acetonitrile. This means that methanol forms a solvent sheath around gramicidin-S, and the bulk is composed of acetonitrile. As seen in the figure, the CD curve at this salt concentration is distinctly different from that of gramicidin-S with no salt.
No appreciable changes in the CD spectra of gramicidin-S were observed on addition of other mono-and divalent metal ions such as Na+, K+, Ag+, and Mg2+. However, Ca2+, Ba2+ and Sr2+ decrease the molar ellipticity of gramicidin-S but do not give the same type of CD curve as that with lithium. The plot of relative molar ellipticity versus lithium perchlorate concentration for gramicidin-S is given in Fig. 5 . 
NMR
DISCUSSION
The CD and nmr results of the effect of lithium salt on valinomycin and gramicidin-S clearly show that the nature of the interaction of the salt is different in the two cases. In the case of valinomycin, the two plateau regions in the titration graphs, one at low (Fig. 2) and the other at high (Fig.  3) salt concentrations, indicate two different processes or conformations for the molecule at these concentrations. In the case of gramicidin-S, the effect on the CD and nmr spectra is observed only at high lithium salt concentrations. The effects observed at high salt concentration for both valinomycin and gramicidin-S could only be due to similar interactions affecting the structural stability of the peptide. The changes in the spectral parameters at low salt concentrations (<0.5M salt), only in the case of valinomycin, are due to the binding of the lithium ion to valinomycin. The absence of such spectral changes for gramicidin-S at low salt concentrations (<0.5M; Fig. 2) indicates only that gramicidin-S does not bind the lithium ion.
Complexation of Lithium by Valinomycin
Analysis of the CD data by the method of Rose and Henkens12 showed that the valinomycin-lithium complex has a 1:l stoichiometry with weak binding, as shown by the stability constant obtained, i.e., 48.1 f 0.5 L mol-l. The data do not fit any equilibrium with other stoichiometry or any multiple equilibria-this has been checked by Reuben'sL3 method. Although all IA group metal'ions are known to form complexes of the valinomycin-potassium type, lithium, according to this study, forms a very different type. This conformation, proposed for the valinomycin-lithium complex, where the ion is bound to one side of the bracelet, is a direct demonstration of the possible complexation reaction at the membranewater interface.
Effect of High Salt Concentrations
Lithium has been shown to bind to the amide carbonyl group of amides,lPl7 as well as to various charged groups that may be available on the peptides.2 The binding of lithium to amide carbonyls is drastically affected by the presence of even small amounts of water, and this has to be taken into account when denaturation data at high salt concentrations are interpreted. Denaturation of proteins and polypeptides involves disruption of intramolecular hydrogen bonds. A t high salt concentrations, the conformational transitions exhibited could be due either to ion binding or to solvent structural changes.18J9
Figures 3 and 5 show a sudden conformational transition at high lithium concentration (>3M) for both valinomycin and gramicidin-S, and this is possibly due to breaking of the structure at such high salt concentrations. The upfield shift of the carbonyl carbon chemical shift is consistent with this. As we have already discussed, at low salt concentrations the lithium ion binds to valinomycin, forming a 1: 1 type complex, whereas it does not bind to gramicidin-S. This suggests that ion binding and denaturation are independent of each other and that the conformational transition at high salt concentrations is not a consequence of ion binding. Lithium, a highly solvating ion, removes the solvent sheath around the depsipetide, and this occurs at high salt concentration. The loss in the enthalpy of solvation of the depsipeptide is made up, in part, by an increase in the entropy accompanying the structure breaking. Also, if ion binding assisted in the structure breaking, we would expect divalent metal ions to be more effective than monovalent ions. The fact that the effectiveness of the metal ions follows the Hofmeister series18 can be interpreted as being due to solvent structural changes. We believe, therefore, that, whether ionophoric or not, the conformational transitions at high salt concentrations are not driven by ion binding. Any net binding of lithium is due t o binding to the carbonyls exposed by structure breaking.
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